Experience

Dewpoint Therapeutics

• United States
• Biotechnology Research
• 100 - 200 Employee

• Senior Scientist

  • Nov 2021 - Apr 2023

  Collaborate across teams to develop a new anticancer/antiviral strategy by degrading the latent antigen of an oncogenic virus with PROTACs Collaborate across teams to develop a new anticancer/antiviral strategy by degrading the latent antigen of an oncogenic virus with PROTACs



Harvard Medical School

• United States
• Higher Education
• 700 & Above Employee

• Research Associate

  • 2017 - 2021

  Led a collaborative project in the discovery of new inhibitors that target the two subunit interactions of human cytomegalovirus nuclear egress complex Discovered a novel antiviral drug resistant mechanism Initiated a new study to investigate the association between antiviral drug resistance and host DNA repair (NIH R03 grant awardee, principal investigator, 2019 ~ 2021) Led a collaborative project in the discovery of new inhibitors that target the two subunit interactions of human cytomegalovirus nuclear egress complex Discovered a novel antiviral drug resistant mechanism Initiated a new study to investigate the association between antiviral drug resistance and host DNA repair (NIH R03 grant awardee, principal investigator, 2019 ~ 2021)



Microbiotix

• Worcester,MA

• Senior Scientist

  • 2015 - 2016

  Investigated the mechanism action of the leading drug candidates in company's pipeline Led a collaborative project to discover new inhibitors that target early steps of human cytomegalovirus replication cycle Investigated the mechanism action of the leading drug candidates in company's pipeline Led a collaborative project to discover new inhibitors that target early steps of human cytomegalovirus replication cycle



Harvard Medical School

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Fellow

  • 2009 - 2015

  Discovered and delineate a novel drug resistance mechanism Led a collaborative project to discover new inhibitors targeting the subunit interactions of human cytomegalovirus DNA polymerase Discovered and delineate a novel drug resistance mechanism Led a collaborative project to discover new inhibitors targeting the subunit interactions of human cytomegalovirus DNA polymerase